Key result
The Brazilian Portuguese version of the Anticoagulation Knowledge Tool (AKT-Br) demonstrated satisfactory reliability and validity, with median scores of 29.0 for pharmacists and 17.0 for patients.
Why the study?
Warfarin carries a high risk of serious adverse effects if used incorrectly, motivating the translation, cultural adaptation, and validation of the Anticoagulation Knowledge Tool into Brazilian Portuguese.
Cross-Sectional
The AKT-Br is a reliable and valid tool for assessing knowledge about oral anticoagulants among Brazilian Portuguese speakers.
May aid identification of anticoagulation knowledge gaps in Brazil; supports AKT-Br validity but leaves open outcome links.
INTRODUCTION: Oral anticoagulants are the treatment of choice for diverse types of coagulation disorders. Warfarin is widely used by the Brazilian population, possibly due to its lower cost than other oral anticoagulants. However, it has a high risk of serious adverse effects if used incorrectly. The Anticoagulation Knowledge Tool (AKT) can assess a patient's knowledge about her/his oral anticoagulant therapy and can assist health professionals in identifying patients with difficulties in adherence. This study aimed to translate, culturally adapt, and validate the AKT into Brazilian Portuguese. METHODS: After a standard forward-backward procedure to translate the AKT into Brazilian Portuguese (AKT-Br), a version of the instrument was applied in three groups (patients, pharmacists, and the general population). The reliability of the AKT-Br was tested using an internal consistency measure and test-retest. The validity of the instrument was confirmed with data from the contrasted groups. All statistical analyses were performed with RStudio. RESULTS: The median scores obtained with the AKT-Br were 29.0, 17.0, and 7.5 for pharmacists, patients, and the general population, respectively (maximum score of 35 points). There was moderate internal consistency for the instrument and test-retest reliability was satisfactory. Analysis of variance for validity of the groups revealed a significant relationship between the total score and the evaluated groups. CONCLUSION: The ATK-Br is a reliable and valid tool to assess knowledge about oral anticoagulants. AKT-Br can be used in clinical practice as an auxiliary tool to improve patient care through personalised educational interventions.
No takes yet. Share an insight, caveat, or question.
Mainka et al. (2022) conducted a cross-sectional in Oral anticoagulant therapy. Anticoagulation Knowledge Tool (AKT-Br) vs. Pharmacists vs patients vs general population was evaluated on AKT-Br score. The Brazilian Portuguese version of the Anticoagulation Knowledge Tool (AKT-Br) demonstrated satisfactory reliability and validity, with median scores of 29.0 for pharmacists and 17.0 for patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: